|
Synonyms: SB-240683
Compound class:
Antibody
Comment: Pascolizumab targets interleukin 4 (IL4).
|
| No information available. |
Summary of Clinical Use  |
| Pascolizumab is in Phase 2 clinical trial for asthma (see NCT00024544) and pulmonary tuberculosis (TB; see NCT01638520). |
